polysaccharid
microarray
platform
prepar
immobil
burkholderia
pseudomallei
burkholderia
mallei
polysaccharid
polysaccharid
array
test
success
detect
b
pseudomallei
b
mallei
serum
human
anim
antibodi
advantag
microarray
technolog
current
serodiagnosi
bacteri
infect
discuss
great
deal
emphasi
develop
dna
protein
microarray
recent
dietrich
schweiter
et
al
howev
dna
protein
microarray
fail
address
glycosyl
posttransl
modif
mani
gramneg
bacteria
contain
structur
uniqu
polysaccharid
name
capsular
polysaccharid
lipopolysaccharid
lp
oantigen
often
pathogen
specif
raetz
whitfield
word
polysaccharid
bsignatur
polysaccharidesq
respect
bacteria
possibl
immobil
microbi
polysaccharid
glass
slide
use
microarray
sera
infect
immun
anim
human
could
use
bind
array
polysaccharid
microarray
technolog
use
novel
approach
diagnosi
bacteri
infect
hirabayashi
feizi
mulloy
love
seeberg
thirumalpura
et
al
blixt
et
al
willat
et
al
inde
employ
carbohydr
microarray
use
immobil
microbi
polysaccharid
klebsiellatyp
pneumococcu
type
ctype
vii
type
xiv
meningococcu
group
b
haemophilu
influenza
type
escherichia
coli
demonstr
recent
diagnos
microbi
infect
wang
et
al
applic
glycan
array
identif
immunolog
target
viral
pathogen
sever
acut
respiratori
syndrom
coronaviru
also
report
wang
lu
therefor
carbohydr
polysaccharid
microarray
emerg
technolog
promis
altern
dna
protein
microarray
present
studi
gener
polysaccharid
microarray
surfac
immobil
onto
glass
slide
use
polysaccharid
deriv
burkholderia
pseudomallei
burkholderia
mallei
probe
antisera
contain
antibodi
specif
capsular
polysaccharid
common
pathogen
b
pseudomallei
b
mallei
infect
known
melioidosi
glander
respect
cheng
curri
waag
deshaz
wood
et
al
melioidosi
endem
primarili
southeast
asia
northern
australia
glander
natur
found
equin
occasion
transmit
infect
human
b
mallei
b
pseudomallei
center
diseas
control
prevent
cdc
categori
b
biothreat
agent
rotz
et
al
polysaccharid
microarray
describ
studi
success
use
detect
anticapsul
antibodi
serum
rabbit
immun
purifi
b
pseudomallei
capsular
polysaccharid
convalesc
serum
human
infect
b
mallei
srinivasan
et
al
applic
array
technolog
could
extend
diagnosi
gramneg
bacteri
infect
bacteri
strain
use
studi
b
pseudomallei
deshaz
et
al
b
pseudomallei
atkin
et
al
b
pseudomallei
deshaz
et
al
b
mallei
atcc
strain
produc
common
capsular
polysaccharid
b
pseudomallei
produc
atyp
lp
oantigen
atkin
et
al
b
pseudomallei
lp
oantigen
mutant
b
pseudomallei
strain
grown
luriabertani
lb
agar
lennox
st
loui
mo
lb
broth
lennox
b
mallei
strain
grown
lb
agar
lb
broth
contain
glycerol
cultur
condit
b
pseudomallei
b
mallei
shown
burtnick
et
al
produc
capsular
polysaccharid
lp
polysaccharid
capsular
polysaccharid
lp
extract
bacteri
cell
pellet
hot
phenol
extract
method
purifi
digest
dnase
rnase
proteinas
k
digest
essenti
method
describ
previous
burtnick
et
al
brett
wood
isol
polysaccharid
hydrolyz
acet
acid
h
releas
lipid
moieti
remov
centrifug
filtrat
amicon
centrifug
devic
mw
cutoff
polyclon
rabbit
antibodi
rais
b
pseudomallei
capsular
polysaccharideflagellin
protein
conjug
kindli
provid
de
wood
calgari
alberta
canada
detail
prepar
specif
antibodi
previous
publish
reckseidl
et
al
human
convalesc
serum
collect
individu
accident
laboratori
exposur
b
mallei
present
clinic
symptom
glander
infect
srinivasan
et
al
normal
preinfect
serum
also
collect
time
collect
serum
exposur
approxim
month
minim
risk
protocol
collect
blood
sampl
approv
institut
review
board
unit
state
armi
medic
research
institut
infecti
diseas
usamriid
human
use
committe
hp
donor
provid
inform
consent
met
elig
criteria
polysaccharid
convert
glycosylamin
presenc
ammonium
acet
reduct
amin
spiro
spiro
briefli
dri
polysaccharid
reactivi
pierc
rockford
il
al
moll
sodium
cyanoborohydrid
moll
ammonium
acet
ph
ad
cap
vial
incub
h
distil
deioniz
water
al
al
moll
formic
acid
ad
content
dri
speed
vac
ammonium
acet
reaction
mixtur
remov
addit
methanol
ml
time
follow
repeat
dri
speed
vac
glycosylamin
deriv
polysaccharid
reconstitut
ml
distil
deioniz
water
neutral
sugar
content
polysaccharid
estim
phenolsulfur
acid
method
micropl
format
masuko
et
al
use
lrhamnos
standard
glycosylamin
polysaccharid
print
glass
slide
super
epoxi
nunc
rochest
ny
use
robot
microarray
virtek
chip
writer
pro
biorad
hercul
ca
custom
print
carri
kam
tek
gaithersburg
md
polysaccharid
reconstitut
trisbuff
salin
tb
mmoll
tri
moll
nacl
ph
array
differ
dilut
triplic
origin
concentr
polysaccharid
atcc
micromol
rhamnos
equival
per
millilit
respect
also
use
inulin
sigma
neg
control
amol
glucos
equival
per
millilit
slide
block
al
wtvol
bovin
serum
albumin
sigma
st
loui
mo
tb
h
room
temperatur
h
incub
room
temperatur
al
dilut
rabbit
polyclon
serum
specif
b
pseudomallei
capsular
polysaccharid
tb
slide
wash
time
tb
contain
tween
min
interv
serum
case
human
glander
also
use
dilut
tb
antirabbit
igg
h
l
secondari
antibodi
purchas
amersham
bioscienc
piscataway
nj
antihuman
igg
h
l
kpl
gaithersburg
md
secondari
antibodi
label
bifunct
nh
nhydroxysuccinimid
ester
dye
use
amersham
bioscienc
kit
secondari
antibodi
use
dilut
tb
wash
slide
scan
fluoresc
nm
nm
gene
pix
axon
scanner
use
softwar
gene
pix
pro
gener
scheme
approach
polysaccharid
microarray
outlin
fig
mixtur
capsular
polysaccharid
oantigen
saccharid
isol
differ
bacteri
strain
includ
atcc
lp
mutant
produc
capsular
polysaccharid
oantigen
saccharid
presenc
capsular
polysaccharid
polysaccharid
prepar
confirm
western
blot
diagram
shown
use
polyclon
antibodi
specif
capsular
polysaccharid
burtnick
et
al
polysaccharid
convert
glycosylamin
reduct
amin
sodium
cyanoborohydrid
presenc
ammonium
acet
investig
whether
immobil
polysaccharid
macromolecul
preserv
antigen
determin
print
polysaccharid
capsular
polysaccharid
lp
oantigen
prepar
differ
strain
b
mallei
b
pseudomallei
glass
slide
slide
probe
polyclon
antibodi
specif
capsular
polysaccharid
b
mallei
b
pseudomallei
encapsul
polysaccharid
structur
capsular
polysaccharid
homopolym
mannoheptopyranos
perri
et
al
knirel
et
al
strain
use
studi
shown
contain
capsular
polysaccharid
atkin
et
al
deshaz
et
al
reckseidl
et
al
deshaz
et
al
appar
immunoreact
polysaccharid
preserv
even
surfac
immobil
evidenc
recognit
reactiv
antibodi
specif
capsular
polysaccharid
fig
clear
antibodi
gave
weaker
signal
polysaccharid
deriv
compar
strain
expect
rabbit
antiserum
react
inulin
polysaccharid
use
neg
control
furthermor
use
microarray
abl
detect
capsular
polysaccharid
antibodi
serum
human
patient
srinivasan
et
al
expos
b
mallei
infect
although
antibodi
present
convalesc
serum
absent
preinfect
serum
patient
fig
possibl
glander
patient
serum
also
contain
antibodi
lp
oantigen
requir
investig
present
studi
abl
demonstr
use
polysaccharid
microarray
technolog
detect
serum
antibodi
b
mallei
b
pseudomallei
indirect
hemagglutin
complement
fixat
cf
test
routin
procedur
serolog
diagnosi
human
melioidosi
caus
b
pseudomallei
infect
alexand
et
al
wuthiekanum
et
al
b
mallei
infect
glander
hors
serolog
diagnos
employ
cf
test
marek
manning
indirect
hemagglutin
cf
test
base
crude
wholecel
prepar
extract
bacteria
therefor
potenti
falseposit
serodiagnosi
rule
marek
manning
werneri
et
al
werneri
et
al
neubauer
fig
immunoreact
burkholderia
polysaccharid
microarray
polyclon
rabbit
antiserum
rais
purifi
b
pseudomallei
capsular
polysaccharid
concentr
polysaccharid
decreas
order
triplic
right
lane
left
lane
secondari
antibodi
react
microarray
describ
text
posit
spot
seen
diagram
shown
probe
normal
serum
fig
typic
immunoreact
burkholderia
polysaccharid
microarray
serum
human
glander
patient
microarray
react
preinfect
postinfect
sera
human
glander
patient
dilut
secondari
antibodi
react
microarray
describ
text
immunoreact
also
seen
dilut
well
diagram
shown
et
al
suggest
import
serolog
test
use
wellcharacter
antigen
place
crude
bacteri
prepar
avoid
diagnosi
fals
posit
present
studi
use
wellcharacter
antigen
capsular
polysaccharid
oantigen
saccharid
microarray
circumv
problem
fals
posit
futur
serodiagnosi
b
mallei
b
pseudomallei
infect
